Sonnenblick, Amir
de Azambuja, Evandro
Azim, Hatem A. Jr
Piccart, Martine
Article History
First Online: 7 October 2014
Competing interests
: E.d.A. holds an advisory role for and has received research funding from GlaxoSmithKline. H.A.A. is a consultant for Celgene, Nanostring and Novartis, and has received honouraria from Celgene, GlaxoSmithKline, Nanostring and Novartis. M.P. is a consultant to, and has received honouraria and grant support from, Amgen, Bayer, Boehringer, Bristol-Myers Squibb, Roche and Sanofi; M.P. has also received grant support from Pfizer and honouraria from AstraZeneca. A.S. declares no competing interests.